About 9M India
9M India Limited is a pharmaceutical formulation company specializing in the manufacturing of generic and contract-manufactured medicines. Established in 2020, the company operates as a public unlisted Indian entity headquartered in Chhattisgarh.
Despite being relatively young, 9M India has rapidly built a strong reputation for quality, affordability, and innovation in healthcare. Its manufacturing facilities comply with stringent WHO-GMP standards and are supported by advanced in-house analytical laboratories, ensuring precision, consistency, and regulatory compliance.
Driven by its mission to make quality healthcare accessible to all, 9M India continues to diversify its product portfolio and expand across domestic and international markets.
Challenges
As a fast-growing pharmaceutical enterprise, 9M India faced difficulties in preparing accurate financial documentation and cash flow projections required for credit assessments and loan restructuring.
Limited internal financial bandwidth and lack of specialized expertise led to delays in submissions and restricted the company’s ability to negotiate favorable borrowing terms—especially during critical phases of expansion and capital infusion.
Our Strategic Approach
BankKeeping provided end-to-end financial and banking strategy support through its Quick CMA (Credit Monitoring Arrangement) service.
The team conducted a thorough analysis of 9M India’s financial statements, working capital cycles, and growth plans, developing a comprehensive CMA report fully aligned with lender requirements.
Beyond documentation, BankKeeping also advised on key financial ratios, collateral structuring, and rate optimization—strengthening the company’s credit profile and ensuring a more informed negotiation with banks.
Results Delivered
With BankKeeping’s intervention, 9M India achieved measurable improvements in both financial accuracy and presentation quality.
- Faster sanction and renewal of working capital facilities
- Improved loan terms through stronger financial representation
- Enhanced internal documentation and financial discipline
- Increased readiness for future funding and expansion
This transformed the company’s funding experience from reactive to strategically proactive.
How Bankkeeping optimizes your banking cost
With streamlined reporting and an elevated credit profile, 9M India can now focus on scaling manufacturing capabilities, entering new markets, and accelerating its growth journey—backed by financial clarity and confidence.
BankKeeping doesn’t just create CMA reports—it builds financial strategies that help businesses secure better funding, reduce borrowing costs, and sustain growth through informed decision-making.
→ Optimize your banking and funding strategy today — Talk to BankKeeping.
